Effects of hypertension and obesity on endometrial thickness.
OBJECTIVE
The aim of this study was to evaluate the effects of hypertension and obesity on endometrial thickness.


METHODS
Forty obese women with hypertension (Group 1), 28 non-obese women with hypertension (Group 2), 58 obese women (Group 3), 56 non-obese healthy women (Group 4), totally 182 postmenopausal women were included in this prospective study. All patients were examined, and Papanicolaou cervical smear was performed after interview. Endometrial thickness was measured in the anterior-posterior diameter by vaginal ultrasonography. The data were analysed with one-way analyses of variance (ANOVA), Scheffe and chi2 tests. P<0.05 was accepted as statistically significant.


RESULTS
Endometrial thickness in obese women with or without hypertension were significantly greater than in non-obese women with or without hypertension (P<0.05). There was no statistical difference between non-obese hypertensive women and control group regarding endometrial thickness measurement (P>0.05).


CONCLUSIONS
Obesity has been found to increase endometrial thickness independently. Hypertension may increase the endometrial thickness if it is combined with obesity.
Serin
Ibrahim Serdar
IS
Departments of Obstetrics and Gynecology, University of Erciyes, 38039 Kayseri, Turkey. serdarserin@hotmail.com
Ozçelik
Bulent
B
Basbug
Mustafa
M
Ozsahin
Olcay
O
Yilmazsoy
Ayse
A
Erez
Rusen
R
D015992:Body Mass Index; D004717:Endometrium / Q000000981:diagnostic imaging / Q000473:pathology*; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000473:pathology*; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000473:pathology*; D065006:Papanicolaou Test; D017698:Postmenopause; D011446:Prospective Studies; D014463:Ultrasonography; D014626:Vaginal Smears
D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone